- Home
- ESRT vs SPRY Comparison
ESRT vs SPRY Comparison
Compare ESRT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESRT
- SPRY
- Stock Information
- Founded
- ESRT 2011
- SPRY 2015
- Country
- ESRT United States
- SPRY United States
- Employees
- ESRT N/A
- SPRY N/A
- Industry
- ESRT Real Estate Investment Trusts
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- ESRT Real Estate
- SPRY Health Care
- Exchange
- ESRT Nasdaq
- SPRY Nasdaq
- Market Cap
- ESRT 1.2B
- SPRY 1.1B
- IPO Year
- ESRT 2013
- SPRY N/A
- Fundamental
- Price
- ESRT $7.65
- SPRY $9.78
- Analyst Decision
- ESRT Hold
- SPRY Strong Buy
- Analyst Count
- ESRT 2
- SPRY 4
- Target Price
- ESRT $10.65
- SPRY $31.25
- AVG Volume (30 Days)
- ESRT 1.6M
- SPRY 2.5M
- Earning Date
- ESRT 10-29-2025
- SPRY 11-12-2025
- Dividend Yield
- ESRT 1.86%
- SPRY N/A
- EPS Growth
- ESRT N/A
- SPRY N/A
- EPS
- ESRT 0.24
- SPRY N/A
- Revenue
- ESRT $763,746,000.00
- SPRY $112,339,000.00
- Revenue This Year
- ESRT $2.27
- SPRY N/A
- Revenue Next Year
- ESRT $3.04
- SPRY $186.14
- P/E Ratio
- ESRT $31.39
- SPRY N/A
- Revenue Growth
- ESRT 1.14
- SPRY 22367.80
- 52 Week Low
- ESRT $6.56
- SPRY $9.34
- 52 Week High
- ESRT $11.55
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- ESRT 55.21
- SPRY 38.43
- Support Level
- ESRT $7.10
- SPRY $9.75
- Resistance Level
- ESRT $7.46
- SPRY $10.38
- Average True Range (ATR)
- ESRT 0.21
- SPRY 0.60
- MACD
- ESRT -0.01
- SPRY 0.02
- Stochastic Oscillator
- ESRT 71.15
- SPRY 5.41
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.